Prescription medications are intended to treat conditions that you have been diagnosed with, but some research suggests that certain medications may have a nasty and unwanted side effect.
A recent study suggests that certain medications may increase the risk of developing dementia.
Advertisement
Cases of dementia and Alzheimer’s disease are on the rise as the world’s population is aging, but medications may be playing a role in increasing these cases too.
The researchers focused on medications with anticholinergic effects. These drugs block acetylcholine, a chemical messenger, which affects muscle activity in the digestive and urinary tracts, lungs, and other areas of the body. It also plays a role in memory and learning.
Nearly all medications have some anticholinergic effect and estimates suggest that nearly half of older Americans are taking at least one type of medication.
Exampled of these types of medications include amitriptyline, paroxetine, and bupropion (depression medications), oxybutynin and tolterodine (overactive bladder medication), and diphenhydramine (antihistamine).
The researchers collected data from over 300,000 older adults and compared medication use and dementia diagnosis with those not diagnosed with dementia.
The researchers found that those who took medications with anticholinergics had an 11 percent higher risk of being diagnosed with dementia. The higher the anticholinergic, the higher the risk of dementia.
Although the findings of the study do offer some insight into a possible link between certain medications and dementia risk, the findings are not definitive and you shouldn’t stop taking prescribed medications unless otherwise instructed.
Advertisement
Furthermore, the study only looked at a large group and not individual risk factors which could increase a person’s risk for dementia.
If you’re concerned about your medications and memory, speak to your doctor.
Also read:
- Elderly Are at Higher Risk of Dementia with the Decline in Walking Speed
- How dementia progresses: The 7 stages of dementia
Mohan Garikiparithi got his degree in medicine from Osmania University (University of Health Sciences). He practiced clinical medicine for over a decade before he shifted his focus to the field of health communications. During his active practice he served as the head of the Dept. of Microbiology in a diagnostic centre in India. On a three-year communications program in Germany, Mohan developed a keen interest in German Medicine (Homoeopathy), and other alternative systems of medicine. He now advocates treating different medical conditions without the use of traditional drugs. An ardent squash player, Mohan believes in the importance of fitness and wellness.
